New Zealand markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
218.72+0.66 (+0.30%)
As of 10:30AM EDT. Market open.
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
1,049,900
3,419,300
2,261,400
1,331,200
-
Other short-term investments
0
1,473,500
1,541,100
1,278,900
-
Total cash
1,049,900
4,892,800
3,802,500
2,610,100
-
Net receivables
2,100,000
2,136,400
1,961,700
2,327,300
-
Inventory
2,527,400
1,344,400
1,351,500
1,068,600
-
Other current assets
1,182,000
1,417,600
740,800
881,100
-
Total current assets
6,859,300
9,791,200
7,856,500
6,887,100
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,132,200
5,868,200
5,798,400
5,627,100
-
Accumulated depreciation
-2,402,500
-2,165,700
-2,006,600
-1,782,300
-
Net property, plant and equipment
3,729,700
3,702,500
3,791,800
3,844,800
-
Equity and other investments
0
705,700
892,000
772,100
-
Goodwill
6,219,200
5,749,000
5,761,100
5,762,100
-
Intangible assets
8,363,000
1,850,100
2,221,300
3,084,300
-
Other long-term assets
745,000
1,529,200
1,939,500
2,899,000
-
Total non-current assets
19,985,500
14,762,900
16,020,800
17,731,800
-
Total assets
26,844,800
24,554,100
23,877,300
24,618,900
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
150,000
-
999,100
-
1,495,800
Accounts payable
403,300
491,500
589,200
454,900
-
Accrued liabilities
1,450,100
1,378,900
2,190,100
2,630,000
-
Other current liabilities
838,400
746,900
10,800
181,500
-
Total current liabilities
3,434,300
3,272,800
4,298,200
3,742,200
-
Non-current liabilities
Long-term debt
6,788,200
6,281,000
6,274,000
7,426,200
-
Deferred tax liabilities
641,800
334,700
694,500
1,032,800
-
Other long-term liabilities
781,100
944,200
1,320,500
1,329,600
-
Total non-current liabilities
8,611,100
7,892,900
8,619,400
10,190,600
-
Total liabilities
12,045,400
11,165,700
12,917,600
13,932,800
-
Stockholders' equity
Common stock
100
100
100
100
-
Retained earnings
17,627,600
16,466,500
13,911,700
13,976,300
-
Accumulated other comprehensive income
-153,700
-164,900
-106,700
-299,000
-
Total stockholders' equity
14,799,400
13,397,900
10,896,200
10,700,300
-
Total liabilities and stockholders' equity
26,844,800
24,554,100
23,877,300
24,618,900
-